Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$91.95+0.37 (+0.40%)
Close on Nov 17, 2026Market cap $5.97BP/E –Yield –
Mirum Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Mirum Pharmaceuticals's price to sales ratio was 9.9× on Nov 11, 2026, against 7.9× a year earlier. Over the last 5 years it ranged from 5.8× to 38.0×, with a median of 10.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.9× | +1.3 |
| 2025 | Dec 31, 2025 | 8.6× | +2.1 |
| 2024 | Dec 31, 2024 | 6.5× | −11.4 |
| 2023 | Dec 29, 2023 | 17.8× | +4.1 |
| 2022 | Dec 30, 2022 | 13.7× | −16.6 |
| 2021 | Dec 31, 2021 | 30.3× | – |
See a number that looks wrong?